💨 Abstract

The National Pharmaceutical Pricing Authority (NPPA) has approved a 50% increase in the ceiling prices of eleven essential drugs to maintain their availability for public health needs. This decision, made on October 8, aims to address manufacturers' financial viability due to rising costs of Active Pharmaceutical Ingredients, production expenses, and exchange rate fluctuations.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖